Insomnia China Prescription Drug Sales Data 2010Draco Healthcare Consulting LLCAugust 1, 2011 SKU: DCO6482757 |
Additional Information
- 1. Top 20 Pharmaceutical Companies in China’s Anti-Allergic Drug Market (At least >0.84% of the Chinese anti-allergic drug market)
- Chongqing Huabang
- India Ranbaxy Labs
- Shenzhen Xinlitai
- Zhejiang Hangzhou Aoyi Baoling
- Beijing Shuanglu
- Chengdu Minyi
- Chongqing Kailin
- Guangdong Zhuhai Lianbang
- Hainan Puli
- Henan Sanmenxia Sainuo
- Hubei Yidu Dongyang
- Jiangsu Changzhou No 4 Pharma
- Jiangsu Lianhuan
- Nanjing Yihua
- Schering-Plough China
- Shandong Lunan
- Shenzhen Haibin
- Suzhou Weicai
- UCB
- Xian-Janssen
- 2. Top 20 Pharmaceutical Companies in China’s Anti-Asthma Drug Market(At least > 0.53% of the Chinese anti-asthma drug market)
- Boehringer Ingelheim
- Zhejiang Beisheng
- AstraZeneca
- GSK
- Guangdong Huanqiu
- Guangzhou Maite-Xinghua
- Guilin Nanyao
- Hangzhou MSD China
- Heilongjiang Fuhe Huaxing
- Draco
- Henan Kaifeng Kangnuo
- Hengyang Hengsheng
- Jiangsu China Medicine and Technology University
- Otsuka Pharmaceutical Co Ltd
- Qingzhou Yaowang
- Sankyo
- Shandong Hualu
- Shandong Ruiyang
- Shanghai Aidifa
- Sichuan Chengdu Huayu
- Zhejiang Changxing
- 3. Top 20 Pharmaceutical Companies in China’s Anti-BPH Drug Market(At least > 0.58% of the Chinese anti-BPH drug market)
- Changchun Yixin
- Madaus AG
- Polichem S.A.
- Xian Lijun
- Zhejiang Hailisheng
- Abbott Shanghai
- Beijing Saike
- Byk Gulden
- Hangzhou Sanofi-Synthelabo
- Hebei Taiyangshi
- Henan Tianfang
- Jiangsu Lianhuan
- Merck Sharp & Dohme MSD China
- Nanjing Meirui
- Pfizer Dalian
- Shandong Lunan
- Tianjin Tong Ren Tang
- Yamanouchi (Astellas)
- Zhejiang Kangenbei
- Zhejiang Xianju
- Draco
- 4. Top 20 Pharmaceutical Companies in China’s Anti-Depressant Drug Market (At least > 0.29% of the Chinese anti-depressant drug market)
- Changzhou Siyao
- Dr.Willmar Schwabe GmbH & Co
- Jiangsu Changzhou Huasheng
- Novartis
- Taiwan Lotus pharmaceutical Co
- Zhejiang Jianfeng
- Chengdu Daxinan
- Eli Lilly & Co
- H.Lundbeck A/S.
- Hunan Dongting
- N.V. Organon
- Pfizer Dalian
- Shanghai Zhongxi
- Sichuan Zhenzhu
- Solvay
- Tianjin Smith Kline & French laboratories Ltd
- Wuxi Huayu
- Wyeth-Whitehall (Suzhou)
- Zhejiang Huahai
- Zhejiang Jingxin
- 5. Top 20 Pharmaceutical Companies in China’s Anti-Dermatosis Drug Market (At least > 1.17% of the Chinese anti- dermatosis drug market)
- Chongqing Huabang
- Novartis
- Xian-Janssen
- Daiichi Seiyaku
- Tianjin Pharmaceutical
- Hong Kong Bright Future
- Schering-Plough China
- Tianjin SmithKline & French Laboratories Ltd.
- Shandong Qilu
- LEO Pharmaceutical
- Laboratories Galderma S.A
- Shanghai Likang
- Draco
- Shanghai Xinyi
- Luitpold-Werk, Chemisch-Pharma, Fabrik
- Bayer
- Jiangsu Jichuan
- Teijin Limited
- Sichuan Dikang
- Zhejiang Hangzhou Yishute
- GSK
- 6. Top 20 Pharmaceutical Companies in China’s Anti-Diabetics Drug Market (At least > 0.57% of the Chinese anti-diabetics drug market)
- Bayer
- Beijing Liling Hengtai
- Beijing Taiyang
- Eli Lilly
- GlaxoSmithKline
- Hangzhou Zhongmei Huadong Pharmaceutical Ltd.
- Jiangsu Hangshen
- Jiangsu Hengrui
- Jiangsu Wangbang BioChem Co
- Novartis
- Novo Nordisk
- Pfizer
- sanofi-aventis
- Servier (Tianjin)
- Shanghai BMS
- Taiji Group Chongqing Fuling Pharmaceutics
- Takeda
- Tonghua Dongbao
- Wanhui Shanghe
- Yangtze River
- Draco
- 7. Top 20 Pharmaceutical Companies in China’s Anti-Fungal Drug Market(At least > 0.51% of the total China’s anti-fungal drug market)
- Shanghai Sunve
- Bayer
- Chengdu Peite
- Chongqing Huabang
- Novartis
- Tianjin Lisheng
- Tianjin Smith Kline & French laboratories
- Xian-Janssen
- Yangtze River
- Zhuhai Yibang
- Abbott
- Alza Corporation
- Chengdu Huashen
- Hangzhou Mingsheng
- Jiangsu Tianhe Disainuo
- MSD
- Pfizer
- Shandong Qilu
- Shanghai Xinxianfeng
- Torrent Pharmaceuticals Ltd
- 8. Top 20 Pharmaceutical Companies in China’s Anti-Hypertension Drug Market (At least > 0.86% of the Chinese anti-hypertension drug market)
- Bayer
- Pfizer
- Novartis
- AstraZeneca
- MSD
- sanofi-aventis
- BMS
- Beijing Saike
- Jilin Tianfeng
- Servier
- Roche
- Merck
- Draco
- Yangtze River
- Boehringer-Ingelheim
- Altana Pharma AG
- Tanabe
- Suzhou Dong Rui Jiangsu Suzhou Dongrui
- Jiangsu Nanjing Xingang
- Beijing Huasu
- Shanghai Xiandai
- 9. Top 20 Pharmaceutical Companies in China’s Anti-Hyperlipidemics Drug Market (At least > 0.31% of the Chinese anti-hyperlipidemics drug market)
- Beijing Baihui
- Beijing Wansheng
- Ethypharm
- Henan Tianfang
- Jiangsu Huarui
- Laboratories Foumier S.A
- Pharmacia & Upjohn (Pfizer)
- Shandong Qilu
- Yangtze River
- Zhejiang Haizheng
- Zhejiang Jingxin
- Beida Weixin
- Beijing Honghui
- BMS
- Guangzhou Nanxin
- MSD
- Novartis
- Pfizer
- Sankyo
- Shandong Lunan
- Draco
- 10. Top 20 Pharmaceutical Companies in China’s Anti-Peptic Ulcer Drug Market (At least > 0.95% of the Chinese anti-peptic ulcer drug market)
- AstraZeneca
- Altana Pharma AG
- Bayer
- Changzhou Siyao
- Guangdong Lizhu
- Guangdong Tuobin
- Hainan Huanglong
- Hangzhou Zhongmei Huadong
- Jiangsu Haoshen
- Seiko Eiyo Yakuhin
- Shandong Luye
- Shandong Lunan
- Shanghai Xinyi
- Shenyang Dongyu
- Sichuan Dikang
- Weicai
- Xian-Janssen
- Yamanouchi
- Yangtze River
- Yangzhou Aosaikang
- 11. Top 20 Pharmaceutical Companies in China’s Sedative Hypnotic Drug Market (At least > 0.96% of the Chinese sedative hypnotic drug market)
- AstraZeneca
- Atlantic Laboratories Corp Ltd
- Changzhou Huasheng
- Chengdu Daxinan
- Eli Lilly & Co
- Guizhou Shengqi
- Guizhou Yikang
- H.Lundbeck A/S
- Hangzhou Sanofi-Synthelabo
- Hunan Dongting
- Kunming Zhiyao
- Roche
- Shandong Qilu
- Draco
- Shanghai Jiufu
- Suzhou No.1
- Wandashan
- Wusulijiang Pharma
- Xian-Janssen
- Xuzhou Enhua
- Zhejiang Yongning
- 12. Top 20 Pharmaceutical Companies in China’s Anti Senile Dementia Drug Market (At least > 0.96% of the Chinese anti senile dementia drug market)
- Harbin Sanlian
- Beijing Shuanghe
- Guangdong Shixin
- Guizhou Yibai
- Hainan Tongyong Sanyang
- Heilongjiang Feixia
- Heilongjiang Zhenbaodao
- Henan Lingrui
- Kunming Longjin
- Nanjing Xiansheng Dongyuan
- Shandong Qilu
- Shanghai Xinxianfeng
- Shanxi Pude
- Shanxi Wanrong
- Shijiazhuang Shenwei
- TRB Pharma S.A.
- Willmar Schwabe
- Yangtze River
- Yunnan Shengwugu Dengzhanhua (Herba Erigerontis)
- Hunan Jianlang
- Draco
- 13. Top 20 Pharmaceutical Companies in China’s Anti-Thrombotic Drug Market (At least > 0.85% of the Chinese anti-thrombotic drug market)
- Anhui Zhaoke
- Beijing Baiao
- Beijing Bituoxi
- Boehringer Ingelheim
- Changchun Haobang
- Changchun Jinyou
- Dalian Meiluo
- Dandong Yichuang
- GSK
- Guangdong Tianpu
- Hainan Bikai
- Hainan Tongyong Tongmeng
- Otsuka
- Pfizer
- sanofi-aventis
- Shenyang Jishi
- Shenzhen Xinlitai
- Tianjin Hongri
- Tianjin Shengwu
- Wuhan Yuanda
- 14. Top 20 Pharmaceutical Companies in China’s Blood Product Drug Market (At least > 1.21 % of the Chinese blood product drug market)
- Guangzhou Baiyunshan Qiaoguang
- Anhui Fengyuan
- Aventis Behring
- B. Braun Melsungen
- Baxter
- Beijing Shuanghe
- Chengdu Rongsheng
- Chongqing Xinan
- Fresenius Kabi
- Green Cross
- Harbin Sanlian
- Hualan Shengwu
- Jiangsu Huarui
- Draco
- Jinzhou Aohong
- Otsuka
- Shanghai RAAS
- Sichuan Kelun
- Sichuan Yuanda Shuyang
- Tianjin Tianan
- Wuxi Nutricia
- 15. Top 20 Pharmaceutical Companies in China’s Ophthalmological Market(At least > 0.88% of the Chinese Ophthalmological drug market)
- Santen Pharmaceutical Co
- Senju Pharmaceutical
- Shanghai Xinyi
- Alcon
- Allergan U.S.A.(US)
- Beijing Zizhu
- Ferring Pharmaceuticals
- Guangdong Zhuhai Lianbang
- Guangdong Zhuhai Yisheng
- Hubei Dongsheng
- Laboratories Leurquin Mediolanum SA
- Lizhu Group
- Novartis
- Otsuka Pharmaceutical Co
- Pharmacia Upjohn (Pfizer)
- Shandong Zhenda Furuida
- Shenyang Xinqi
- Shenzhen Huashengyuan
- Sichuan Shenghe
- Wuhan Wujing
- 16. Top 20 Pharmaceutical Companies in China’s Macrolide Antibiotics Drug Market (At least > 1.04% of the Chinese macrolide antibiotics drug market)
- Abbott
- Beijing Taiyang
- Dongbei Zhiyao
- Guangdong Lizhu
- Draco
- Hainan Sida
- Harbin Pharmaceutical Group
- Jiangsu Hengrui
- Jiangsu Jichuan
- Jiangsu Jinsili
- Pfizer
- Pliva
- POLFA
- Shandong Qilu
- Shenzhen Wanhe
- Shijiangzhuang Pharma
- Sichuan Kelun
- Xian Lijun
- Yangtze River
- Zhejiang Jianfeng
- Zhejiang Zhongyi
- 17. Top 20 Pharmaceutical Companies in China’s Anti-Cancer Drug Market(At least > 1.3 % of the Chinese anti-cancer drug market)
- Jiangsu Hansen Pharmaceutical Co., Ltd.(Hansen Pharma)
- Jiangsu Hengrui Medicine Co., Ltd
- Novartis
- Pfizer
- Roche
- sanofi-aventis
- Sichuan Diao Jiuhong Group Pharmaceutical Co
- AstraZeneca
- Bristol-Myers Squibb
- Eli Lilly
- Guizhou Baiqiang Pharmaceutical Co., Ltd.
- Hainan Zhonghe Pharmaceutical Co., Ltd
- JINLING PHARMACEUTICAL CO.,LTD
- LIVZON Pharmaceutical Group Inc.
- Nanjing Kanghai Pharmaceutical Co., Ltd
- Nanjing Sike Pharmaceutical Co. Ltd
- Qilu Pharmaceutical Co., Ltd
- SciClone Pharmaceuticals Italy S.R.l.
- Shenzhen Wanle Pharmaceutical Co,.Ltd
- Draco
- Zhejiang Hisun Pharmaceutical Co,.Ltd
- 18. Top 20 Pharmaceutical Companies in China’s Rheumatoid Arthritis Drug Market (At least > 1.08% of the Chinese rheumatoid arthritis drug market)
- Beijing Taide
- Boehringer Ingelheim
- Fujian Huitian
- German Fujisawa Deutschland GmbH
- Guilin Tianhe
- Harbin Yuheng
- Heilongjiang Dilong
- Heilongjiang Jiangshi
- Hong Kong Bright Future Pharmaceuticals Factory
- Johnson & Johnson
- Lingnan Pharma Hong Kong
- Novartis
- Nycomed Austria GmbH
- Pfizer
- Rotta Research Laboratorium S.P.A.
- Shanxi Zhongyuanwei
- Suzhou Changzhen Xinkai
- Tianjin SmithKline & French Laboratories Ltd
- Tibet Qizheng Zhangyao
- Zhejiang Haizheng
More Pricing reports by Draco Healthcare Consulting LLC
Senile Dementia China Prescription Drug Sales Data 2010 by Draco Healthcare Consulting LLC
See all reports like this >>2011 China Prescription Drug Sales Database provides the following information: 1) 2010 national sales of individual therapeutic area
2) 2010 national sales ...
More China Pricing reports
China: Market Access Tracker by Decision Resources
Decision Resources’ Market Access Tracker service for the Asia Pacific region explains the challenges and opportunities to gaining and maintaining favorable market access terms in ...
Pharmaceutical Pricing and Reimbursement in China - Series of Mandated Price Cuts Not Effective in Stemming Healthcare Expenditures by GBI Research
Pharmaceutical Pricing and Reimbursement in China - Series of Mandated Price Cuts Not Effective in Stemming Healthcare ExpendituresSummaryGBI Research, the leading business intelligence provider, has ...
The Pharmaceutical Market: China by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
Healthcare, Regulatory and Reimbursement Landscape - China by GlobalData
See all reports like this >>Healthcare, Regulatory and Reimbursement Landscape - ChinaSummaryGlobalData, Industry analysis specialist, has released its new report, “Healthcare, Regulatory and Reimbursement Landscape - China”. The report is ...
More China reports
Eyewear in Hong Kong, China by Euromonitor International
Chinese mainland tourists with a preference for international spectacle brands are the key driver for high volume and value growth. Minimum wage ordinance passed in ...
D&B Country RiskLine Report: China by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: China by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Wine - BRIC (Brazil, Russia, India, China) Industry Guide by MarketLine
See all reports like this >>Datamonitor's Wine - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, ...
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
Pricing Reports
- Oncology Therapeutics Market in India to 2018 - Introduction of Market-Based Pricing to Fuel Price Wars and Intense Competition Among Domestic and Multinational Players
- Healthcare, Regulatory and Reimbursement Landscape - Finland
- Healthcare, Regulatory and Reimbursement Landscape - Austria
- Risk Sharing and Other Forms of Managed Entry Agreements for Medicines, Worldwide
- Acquired Orphan Blood Diseases Therapeutics Market to 2019 - Search for Disease Modifying Drugs Central to Unlocking Premium Pricing Potential
